PATENT CLAIM ANALYSIS

Application Number: 16004921
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "001100"]

Abstract:
A binding moiety (B) for Carbonic Anhydrase IX (CAIX), the binding moiety comprising: The binding moiety is univalent, bivalent, or multivalent. A targeted therapeutic agent may comprise the binding moiety. The invention also includes a method for treating a disease expressing elevated levels of CAIX by administering the targeted therapeutic agent.

Claim (Index 21):
The targeted therapeutic agent of  claim 20 , wherein said binding moiety is a bivalent binding moiety comprising a first binding ligand and a second binding ligand,\n wherein said first binding ligand comprises said terminal moiety of  claim 20 ; and wherein said second binding ligand is selected from the group consisting of ligands having said terminal moiety of  claim 20  and ligands having terminal group wherein R\u2032 is selected from the group consisting of H, optionally substituted C1-C7 alkyl, optionally substituted C1-C7 alkenyl, and optionally substituted C1-C7 heteroalkyl.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.55
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15431310', '15124058', '14722307', '15477721', '13897911']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7585248381838255
- 35 USC 102 Novelty (BERT): 0.5813777715969732
- Combined Prediction Score: 0.7408101315251404
- Mean Citation Score: 324.67310600000013
- Max Citation Score: 537.9128400000002
- Similarity Product: 386.16925125573647

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test